ImmuCell Corporation Inventory, Raw Materials, Gross
ImmuCell Corporation (ICCC) had Inventory, Raw Materials, Gross of $1.51 million as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Inventory
us-gaap:InventoryRawMaterials · last filed 2025-08-14
- 2025-06-30: Inventory, Raw Materials, Gross $1.51M.
- 2025-03-31: Inventory, Raw Materials, Gross $1.56M.
- 2024-12-31: Inventory, Raw Materials, Gross $1.36M.
- 2024-09-30: Inventory, Raw Materials, Gross $1.31M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2025-06-30 | $1.51M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.56M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.36M 10-Q · filed 2025-08-14 | |
| 2024-09-30 | $1.31M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.25M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.27M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.59M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $1.63M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.24M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.11M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.42M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.54M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $2.09M 10-Q/A · filed 2022-11-21 | |
| 2022-03-31 | $1.73M 10-Q/A · filed 2022-11-21 | |
| 2021-12-31 | $971.61K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $641.38K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $829.20K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $660.55K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $631.02K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $575.63K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $647.71K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $590.72K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $791.56K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $686.74K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $636.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $470.50K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $338.99K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $416.14K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $364.92K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $438.86K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $483.33K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $507.61K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $430.23K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $313.65K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $318.44K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $422.27K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $474.02K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $429.64K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $284.33K 10-K · filed 2017-03-30 | |
| 2015-09-30 | $337.54K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $283.79K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $314.32K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $306.44K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $292.36K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $257.75K 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $317.88K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $270.36K 10-K · filed 2015-03-26 | |
| 2013-09-30 | $282.85K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $327.40K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $211.00K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $198.44K 10-K · filed 2014-03-26 | |
| 2012-09-30 | $262.75K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $201.00K 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | $218.10K 10-K · filed 2013-03-28 | $218.00K 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |